Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Squibb Co. Third Quarter Earnings Sneak Peek
Yahoo/Wall St. Cheat Sheet
Monday, October 24, 2011 - 4:06pm
tags:
earnings, Bristol-Myers Squibb
Pfizer’s Anti-Smoking Drug Isn’t Riskier Than Patches, FDA Says
Bloomberg
Monday, October 24, 2011 - 4:06pm
tags:
Pfizer, Chantix, smoking cessation, Sanofi, NicoDerm
Sanofi boasts superior relapse-free rate for Lemtrada in MS study
Fierce Biotech
Monday, October 24, 2011 - 12:03pm
tags:
Lemtrada, Sanofi, MS, multiple sclerosis, Genzyme
Vertex tests shorter Incivek therapy in patient subset
Fierce Pharma
Monday, October 24, 2011 - 12:02pm
tags:
Vertex, Incivek, hepatitis C
Novartis drug helps with psoriasis symptoms -data
Reuters
Monday, October 24, 2011 - 12:00pm
tags:
Novartis, psoriasis, AIN457
Sinovac: The Diamond In The Rough
Seeking Alpha
Monday, October 24, 2011 - 11:58am
tags:
Sinovac Biotech, vaccines
Exelixis: Thyroid Cancer Drug Delays Tumor Growth
TheStreet.com
Monday, October 24, 2011 - 11:38am
tags:
Exelixis, cabozantinib, medullary thyroid cancer
FDA sets date to review Affymax anemia drug
Yahoo/AP
Monday, October 24, 2011 - 11:36am
tags:
FDA, Affymax, anemia, peginesatide, chronic kidney disease
Which Drugmakers Have Overpaid CEOs?
Pharmalot
Monday, October 24, 2011 - 11:07am
tags:
executive pay, Pharma CEOs, Amgen, JNJ, Abbott Laboratories, Miles White, Kevin Sharer, William Weldon
Cubist Pharmaceuticals to Acquire Adolor for $190 Million
Bloomberg
Monday, October 24, 2011 - 11:05am
tags:
Adolor, M&A, Cubist Pharmaceuticals
Is Amylin Pharmaceuticals the Perfect Stock?
Motley Fool
Monday, October 24, 2011 - 11:04am
tags:
Amylin
Abbott, Biogen Idec say multiple sclerosis drug achieved study goal of decreasing relapse
Yahoo/AP
Monday, October 24, 2011 - 11:00am
tags:
Abbott Laboratories, Biogen Idec, MS, multiple sclerosis, daclizumab
Lilly Not Interested in Buying Parts of Abbott, Lechleiter Says
Bloomberg
Monday, October 24, 2011 - 10:59am
tags:
John Lechleiter, Abbott Laboratories, M&A, Eli Lilly
Mengniu Dairy Says It’s Not in Direct Talks With Pfizer on Bid
Bloomberg
Monday, October 24, 2011 - 10:58am
tags:
Pfizer, M&A, Mengniu Dairy, infant formula, Hong Kong, infant nutrition
China Biotech Week In Review: SFDA Releases 2010 Approval Data
Seeking Alpha
Sunday, October 23, 2011 - 11:58am
tags:
China, Zhuhai Hokai Medical Instruments, Simcere, Amerigen Pharma, Lundbeck, Medicilon, Shenzhen Hepalink Pharmaceutical
Mid-size biotechs making their way
Boston Globe, MA
Sunday, October 23, 2011 - 11:56am
tags:
Vertex Pharmaceuticals, Ariad Pharmaceuticals, Ironwood, Curis
Enhanced Income Strategy For Novartis AG
Seeking Alpha
Sunday, October 23, 2011 - 11:24am
tags:
Novartis
6 Cheapest Drug Manufacturers With Perfect Dividends
Seeking Alpha
Sunday, October 23, 2011 - 11:23am
tags:
Sanofi, AstraZeneca, Pfizer, Merck, Novartis, JNJ
Will Abbott's Split Unlock Shareholder Value?
Seeking Alpha
Sunday, October 23, 2011 - 11:21am
tags:
Abbott Laboratories
Amgen Leads Firms In Pancreatic Cancer Drug Chase
InvestorPlace
Sunday, October 23, 2011 - 10:54am
tags:
Amgen, Ganitumab, pancreatic cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.